• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑将中医作为溃疡性结肠炎治疗的辅助疗法。

Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.

机构信息

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, No.16, Nanxiaojie, Dongzhimennei, Beijing 100700, People's Republic of China.

出版信息

Clin Rev Allergy Immunol. 2013 Jun;44(3):274-83. doi: 10.1007/s12016-012-8328-9.

DOI:10.1007/s12016-012-8328-9
PMID:22669756
Abstract

Ulcerative colitis (UC) has been treated with traditional Chinese medicine (TCM) for literally thousands of years. This paper gives an overview of TCM in the management of UC, provides an account of the state of the evidence, identifies gaps in the research base, and makes recommendations for future research. TCM is based on patterns and this influences the selection of the type of herbal medication or manipulation technique used for treatment. The majority of clinical studies on the efficacy of Chinese herbal medicine and acupuncture in the treatment of UC have methodological shortcomings. The extent of heterogeneity in many of these clinical trials, poor design quality of past studies prevent meaningful systematic reviews (SRs) or meta-analysis, although there are positive signs that TCM may be useful in relieving abdominal pain and reducing inflammation. Many unknowns still exist, including the active ingredients within Chinese herbal medicine and the potential for interaction with other drugs or western medications. While there may be a potential role for utilizing TCM in the treatment of UC patients relying on both traditional concepts and modern developments, it should be recognized that there are no studies that irrefutably support the use of TCM in the treatment of UC. Further basic or translational research must be done to elucidate mechanisms of action of these agents, and well-designed and well-conducted clinical studies must also be done to determine efficacy and safety of these agents.

摘要

溃疡性结肠炎(UC)已经使用中药(TCM)治疗了数千年。本文概述了 TCM 在 UC 管理中的应用,介绍了证据现状,确定了研究基础中的差距,并为未来的研究提出了建议。TCM 基于模式,这会影响用于治疗的草药药物或操作技术的类型选择。大多数关于中药和针灸治疗 UC 疗效的临床研究都存在方法学上的缺陷。许多临床试验的异质性程度很高,过去研究的设计质量较差,无法进行有意义的系统评价(SR)或荟萃分析,尽管有一些积极的迹象表明 TCM 可能有助于缓解腹痛和减轻炎症。仍有许多未知数,包括中药中的有效成分以及与其他药物或西药相互作用的可能性。虽然 TCM 在治疗 UC 患者方面可能具有潜在作用,既依赖于传统概念,也依赖于现代发展,但应该认识到,没有研究确凿地支持在 UC 治疗中使用 TCM。必须进行更多的基础或转化研究,以阐明这些药物的作用机制,还必须进行精心设计和良好实施的临床研究,以确定这些药物的疗效和安全性。

相似文献

1
Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.考虑将中医作为溃疡性结肠炎治疗的辅助疗法。
Clin Rev Allergy Immunol. 2013 Jun;44(3):274-83. doi: 10.1007/s12016-012-8328-9.
2
Potential activity of Traditional Chinese Medicine against Ulcerative colitis: A review.中药治疗溃疡性结肠炎的潜在活性:综述。
J Ethnopharmacol. 2022 May 10;289:115084. doi: 10.1016/j.jep.2022.115084. Epub 2022 Feb 5.
3
Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine.铁死亡的抑制:中医药治疗溃疡性结肠炎的新方向。
J Ethnopharmacol. 2024 Apr 24;324:117787. doi: 10.1016/j.jep.2024.117787. Epub 2024 Jan 20.
4
An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis.系统评价和荟萃分析对溃疡性结肠炎的中医证据图谱。
BMC Complement Med Ther. 2021 Sep 13;21(1):228. doi: 10.1186/s12906-021-03387-y.
5
International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of Digestive System Disease of World Federation of Chinese Medicine Societies (2023).世界中医药学会联合会消化病专业委员会国际临床实践指南:溃疡性结肠炎中医药使用(2023)。
Phytother Res. 2024 Feb;38(2):970-999. doi: 10.1002/ptr.8087. Epub 2023 Dec 19.
6
Efficacy and safety of retention enema with traditional Chinese medicine for ulcerative colitis: A meta-analysis of randomized controlled trials.保留灌肠中药治疗溃疡性结肠炎的疗效与安全性:一项随机对照试验的荟萃分析。
Complement Ther Clin Pract. 2021 Feb;42:101278. doi: 10.1016/j.ctcp.2020.101278. Epub 2020 Nov 25.
7
Oral traditional Chinese medication for adhesive small bowel obstruction.口服中药治疗粘连性小肠梗阻。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2.
8
[Traditional Chinese medicine for ulcerative colitis: systematic reviews based on PRIO-harms].[基于PRIO危害的溃疡性结肠炎的中医药系统评价]
Zhongguo Zhong Yao Za Zhi. 2020 Feb;45(3):674-682. doi: 10.19540/j.cnki.cjcmm.20190624.501.
9
[Evidence-based Chinese medicine:theory and practice].[循证中医学:理论与实践]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):1-7. doi: 10.19540/j.cnki.cjcmm.20171127.001.
10
Chinese Medicine in the Treatment of Ulcerative Colitis: The Mechanisms of Signaling Pathway Regulations.中医治疗溃疡性结肠炎:信号通路调控的机制。
Am J Chin Med. 2022;50(7):1781-1798. doi: 10.1142/S0192415X22500756. Epub 2022 Aug 11.

引用本文的文献

1
Integrated serum pharmacochemistry and network pharmacology to reveal the kernel material basis and underlying mechanisms of the fuzi-lizhong pill for ulcerative colitis.整合血清药物化学与网络药理学揭示附子理中丸治疗溃疡性结肠炎的核心物质基础及潜在机制
J Tradit Complement Med. 2024 Jun 6;15(3):307-318. doi: 10.1016/j.jtcme.2024.06.003. eCollection 2025 May.
2
Mechanism of the Proprietary Chinese Medicine "JiuLiWan" to Treat Ulcerative Colitis Revealed by Network Pharmacology, Molecular Docking, and Experimental Verification .基于网络药理学、分子对接及实验验证揭示中成药“九力丸”治疗溃疡性结肠炎的机制
ACS Omega. 2025 May 6;10(19):19598-19613. doi: 10.1021/acsomega.5c00261. eCollection 2025 May 20.
3

本文引用的文献

1
Epigenetics: Concepts and relevance to IBD pathogenesis.表观遗传学:概念及其与 IBD 发病机制的相关性。
Inflamm Bowel Dis. 2012 Oct;18(10):1982-96. doi: 10.1002/ibd.22934. Epub 2012 Mar 8.
2
Herbal medicine in the treatment of ulcerative colitis.草药治疗溃疡性结肠炎。
Saudi J Gastroenterol. 2012 Jan-Feb;18(1):3-10. doi: 10.4103/1319-3767.91726.
3
Inflammatory bowel diseases: emerging therapies and promising molecular targets.炎症性肠病:新兴疗法与有前景的分子靶点
Xiahuo Pingwei San attenuated intestinal inflammation in dextran sulfate sodium-induced ulcerative colitis mice through inhibiting the receptor for advanced glycation end-products signaling pathway.
夏火平胃散通过抑制晚期糖基化终产物信号通路受体减轻葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠的肠道炎症。
J Tradit Chin Med. 2025 Apr;45(2):311-325. doi: 10.19852/j.cnki.jtcm.2025.02.006.
4
Saussurea costus alleviates ulcerative colitis by regulating the gut microbiota and improving intestinal barrier integrity.木香通过调节肠道微生物群和改善肠道屏障完整性来缓解溃疡性结肠炎。
Front Cell Infect Microbiol. 2025 Jan 28;15:1528578. doi: 10.3389/fcimb.2025.1528578. eCollection 2025.
5
Ethyl acetate extract of alleviates DSS-induced ulcerative colitis in C57BL/6 mice.的乙酸乙酯提取物可减轻DSS诱导的C57BL/6小鼠溃疡性结肠炎。 (注:原文中“Ethyl acetate extract of ”后面缺少具体内容)
Front Pharmacol. 2023 Dec 12;14:1229772. doi: 10.3389/fphar.2023.1229772. eCollection 2023.
6
Quality of reporting of integrative Chinese and Western medicine intervention in randomized controlled trials of ulcerative colitis: a review.溃疡性结肠炎中西医结合干预随机对照试验报告质量评价:综述。
Syst Rev. 2023 Dec 8;12(1):228. doi: 10.1186/s13643-023-02402-2.
7
Qingre Xingyu recipe exerts inhibiting effects on ulcerative colitis development by inhibiting TNFα/NLRP3/Caspase-1/IL-1β pathway and macrophage M1 polarization.清热行瘀方通过抑制TNFα/NLRP3/Caspase-1/IL-1β通路和巨噬细胞M1极化对溃疡性结肠炎的发展发挥抑制作用。
Cell Death Discov. 2023 Mar 8;9(1):84. doi: 10.1038/s41420-023-01361-w.
8
Administration of modified Gegen Qinlian decoction for hemorrhagic chronic radiation proctitis: A case report and review of literature.加味葛根芩连汤治疗出血性慢性放射性直肠炎:1例病例报告及文献复习
World J Clin Cases. 2023 Feb 16;11(5):1129-1136. doi: 10.12998/wjcc.v11.i5.1129.
9
The beneficial effects of chloroform extract on a dextran sulfate sodium-induced ulcerative colitis mice model.氯仿提取物对葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠模型的有益作用。
Ann Transl Med. 2023 Jan 31;11(2):35. doi: 10.21037/atm-22-5143. Epub 2022 Nov 28.
10
Potential mechanisms of Lian-Zhi-Fan solution for TNBS-induced ulcerative colitis in rats a metabolomics approach.连栀矾溶液对三硝基苯磺酸诱导的大鼠溃疡性结肠炎的潜在作用机制:代谢组学方法
Front Pharmacol. 2022 Dec 2;13:1014117. doi: 10.3389/fphar.2022.1014117. eCollection 2022.
Front Biosci (Schol Ed). 2012 Jan 1;4(3):1172-89. doi: 10.2741/s324.
4
Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?基因、表观遗传调控与环境因素:在自身免疫性疾病的发展中,哪一个最为重要?
Autoimmun Rev. 2012 Jun;11(8):604-9. doi: 10.1016/j.autrev.2011.10.022. Epub 2011 Oct 25.
5
Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.复方苦参结肠溶胶囊治疗溃疡性结肠炎的疗效和安全性与美沙拉嗪的比较:一项双盲、随机研究。
J Ethnopharmacol. 2012 Jun 1;141(2):592-8. doi: 10.1016/j.jep.2011.08.057. Epub 2011 Sep 6.
6
Biologics - beyond the joints.生物制剂——超越关节。
Autoimmun Rev. 2010 Oct;9(12):820-4. doi: 10.1016/j.autrev.2010.07.011. Epub 2010 Aug 10.
7
[Thinking about the key points in developing guidelines for Chinese and integrated medical clinical therapy].关于制定中西医结合临床治疗指南的要点思考
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Mar;30(3):237-40.
8
Moxibustion for ulcerative colitis: a systematic review and meta-analysis.艾灸治疗溃疡性结肠炎:系统评价和荟萃分析。
BMC Gastroenterol. 2010 Apr 7;10:36. doi: 10.1186/1471-230X-10-36.
9
Systematic review: the costs of ulcerative colitis in Western countries.系统评价:西方国家溃疡性结肠炎的成本。
Aliment Pharmacol Ther. 2010 Apr;31(7):693-707. doi: 10.1111/j.1365-2036.2010.04234.x. Epub 2010 Jan 11.
10
The geoepidemiology of autoimmune intestinal diseases.自身免疫性肠道疾病的地理流行病学。
Autoimmun Rev. 2010 Mar;9(5):A372-8. doi: 10.1016/j.autrev.2009.11.008. Epub 2009 Nov 10.